Pharmacy Times
JULY 16, 2022
With a lack of head-to-head studies comparing combination regimens in frontline metastatic renal cell carcinoma, deciding on how to choose the right regimen can pose a challenge.
Pharmacy Times
JULY 16, 2022
The investigational PCV is designed to target serotypes responsible for 85% of all invasive cases of the disease in individuals aged 65 and older in the United States.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
JULY 16, 2022
With the rapid pace of change in biosimilar payer benefit design, efforts to stay regularly updated on policy changes ahead of time become critical for patient care.
Pharmacy Times
JULY 16, 2022
The nature of CLL being a long-term, incurable disease makes its treatment a challenge as it is more focused toward improving patient’s quality of life.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Pharmacy Times
JULY 16, 2022
Even before the pandemic, pharmacists were playing a really important role in public health, being one of the most accessible health care providers.
Pharmacy Times
JULY 16, 2022
Experts discuss the pros and cons of using oral azacytidine to treat patients with acute myeloid leukemia.
Expert insights. Personalized for you.
49 
Let's personalize your content